4.5 Review

Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Progress towards clinical xenotransplantation

Henk-Jan Schuurman et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Article Biotechnology & Applied Microbiology

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

Caroline J. Breitbach et al.

MOLECULAR THERAPY (2007)

Review Oncology

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

Ta-Chiang Liu et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2007)

Article Biotechnology & Applied Microbiology

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity

Anthony T. Power et al.

MOLECULAR THERAPY (2007)

Article Biotechnology & Applied Microbiology

Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy

Ianko D. Iankov et al.

MOLECULAR THERAPY (2007)

Article Multidisciplinary Sciences

Synergistic antitumor effects of immune cell-viral biotherapy

SH Thorne et al.

SCIENCE (2006)

Article Oncology

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

S Komarova et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Review Oncology

Recent progress in the battle between oncolytic viruses and tumours

KA Parato et al.

NATURE REVIEWS CANCER (2005)

Article Biotechnology & Applied Microbiology

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors

J García-Castro et al.

CANCER GENE THERAPY (2005)

Article Biochemistry & Molecular Biology

Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection

K Morizono et al.

NATURE MEDICINE (2005)

Article Biotechnology & Applied Microbiology

Rescue and propagation of fully retargeted oncolytic measles viruses

T Nakamura et al.

NATURE BIOTECHNOLOGY (2005)

Article Oncology

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases

Z Raykov et al.

INTERNATIONAL JOURNAL OF CANCER (2004)

Article Biotechnology & Applied Microbiology

An oncolytic measles virus engineered to enter cells through the CD20 antigen

AD Bucheit et al.

MOLECULAR THERAPY (2003)

Article Biochemistry & Molecular Biology

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

DF Stojdl et al.

NATURE MEDICINE (2000)